Drug Shortage Report for PMS-PREGABALIN
Report ID | 7486 |
Drug Identification Number | 02359642 |
Brand name | PMS-PREGABALIN |
Common or Proper name | PREGABALIN |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | PREGABALIN |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-05-18 |
Actual start date | |
Estimated end date | 2017-07-31 |
Actual end date | 2017-09-15 |
Shortage status | Resolved |
Updated date | 2017-09-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2017-09-18 | French | Compare |
v10 | 2017-09-18 | English | Compare |
v9 | 2017-06-23 | French | Compare |
v8 | 2017-06-23 | English | Compare |
v7 | 2017-06-16 | French | Compare |
v6 | 2017-06-16 | English | Compare |
v5 | 2017-05-23 | French | Compare |
v4 | 2017-05-23 | English | Compare |
v3 | 2017-05-19 | English | Compare |
v2 | 2017-04-20 | French | Compare |
v1 | 2017-04-20 | English | Compare |
Showing 1 to 11 of 11